Indoco Remedies Gets USFDA Nod To Market Generic Diabetes Drug

Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication.

The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.

Read Also

Domestic Air Passenger Traffic Grows 5.1% To About 138.9 Million In May: ICRA

The company's product is the generic equivalent of Invokamet tablets. Indoco said it plans to produce the medication at its manufacturing facility in Goa. | File/ Representative image

Read Also

Veg Thali To Cost You More, Sees A 9% Jump Compared Non-Veg Thali: Crisil Roti Rice Rate Indicator

The company's product is the generic equivalent of Invokamet tablets.

Indoco said it plans to produce the medication at its manufacturing facility in Goa.

FPJ Shorts

'It's Not Easy To Challenge PM Modi, Many Have Tried But Failed': Swami Avimukteshwaranand Saraswati (VIDEO)

Pune: Four Bangladeshi Nationals Arrested For Illegally Residing In Shirur Taluka

Scary! 60 Baby Cobras Found At Cattle Shed In MP's Mandsaur; Terrifying VIDEO Surfaces

Superman Is A Fan Of Tiger Shroff Starrer Baaghi Franchise; This Viral Video Is The Proof (Watch)

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus. | Photo: Pexels

Read Also

Air India In 'Good Position'; To Retrofit Over 100 Planes: CEO Campbell

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus.

"This milestone underscores our commitment to bringing affordable and effective treatment options to patients managing type 2 diabetes," Indoco Remedies MD Aditi Panandikar said.